The Role of Inflammation in Post-TAVI Outcomes
- PMID: 34817013
- PMCID: PMC8682112
- DOI: 10.36660/abc.20210809
The Role of Inflammation in Post-TAVI Outcomes
Comment on
-
C-reactive Protein as a Prognostic Marker of 1-Year Mortality after Transcatheter Aortic Valve Implantation in Aortic Stenosis.Arq Bras Cardiol. 2021 Nov;117(5):1018-1027. doi: 10.36660/abc.20190715. Arq Bras Cardiol. 2021. PMID: 34817012 Free PMC article. English, Portuguese.
References
-
- Grover FL, Vemulapalli S, Carroll JD, Edwards FH, Mack MJ, Thourani VH, et al. 2016 Annual Report of The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. J Am Coll Cardiol. 2017;69(10):1215-30. - PubMed
-
- Carroll JD, Mack MJ, Vemulapalli S, Herrmann HC, Gleason TG, Hanzel G, et al. STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2020;76(21):2492-516. - PubMed
-
- Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro G, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation. 2011;123(3):299-308. - PubMed
-
- de Brito FS, Jr., Carvalho LA, Sarmento-Leite R, Mangione JA, Lemos P, Siciliano A, et al. Outcomes and predictors of mortality after transcatheter aortic valve implantation: results of the Brazilian registry. Catheter Cardiovasc Interv. 2015;85(5):E153-62. - PubMed
-
- Sinning JM, Wollert KC, Sedaghat A, Widera C, Radermacher MC, Descoups C, et al. Risk scores and biomarkers for the prediction of 1-year outcome after transcatheter aortic valve replacement. Am Heart J. 2015;170(4):821-9. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
